Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Cellular Physiology|October 23, 2019
Circular RNA circFNDC3B protects renal carcinoma by miR-99a downregulationTao Chen, Qinchao Yu, Shixiu Shao, et al.Artificial Cells, Nanomedicine, and Biotechnology|August 29, 2019
The circular RNA hsa-circ-0072309 plays anti-tumour roles by sponging miR-100 through the deactivation of PI3K/AKT and mTOR pathways in the renal carcinoma cell linesTao Chen, Shixiu Shao, Wenxian Li, et al.Experimental and Therapeutic Medicine|December 2, 2015
Carotid stump syndrome: A case reportX U Zhang, Shixiu Shao, Xueping Zheng, et al.Expert Review of Anticancer Therapy|September 19, 2014
Recombinant bacillus Calmette-Guérin in urothelial bladder cancer immunotherapy: current strategiesYonghua Wang, Meng Yang, Qinchao Yu, et al.American Journal of Men'S Health|May 26, 2021
The CYP19A1 (TTTA)n Repeat Polymorphism May Affect the Prostate Cancer Risk: Evidence from a Meta-AnalysisLei Guo, Yanan Liu, Lijun Liu, et al.Tumori|June 6, 2015
B7-H1/PD-1 blockade therapy in urological malignancies: current status and future prospectsLun Yu, Yonghua Wang, Shixiu Shao, et al.Oncotargets and Therapy|August 15, 2014
Silencing B7-H1 enhances the anti-tumor effect of bladder cancer antigen-loaded dendritic cell vaccine in vitroShuo Wang, Yonghua Wang, Jing Liu, et al.European Journal of Medical Research|December 20, 2022
High expression of GMNN predicts malignant progression and poor prognosis in ACCXinzhao Zhao, Xuezhou Zhang, Shixiu Shao, et al.Journal of Surgical Oncology|August 13, 2015
T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survivalMeng Yang, Qinchao Yu, Jing Liu, et al.International Urology and Nephrology|September 24, 2008
Quantitative risk stratification and individual comprehensive therapy for invasive bladder cancers in ChinaHai Tao Niu, Haitao Niu, Shi Xiu Shao, et al.Pageof 1